{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-25-000094","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.157005+00:00","generated_at":"2026-05-17T22:26:51.103331+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GRI Bio reports positive interim biomarker data from Phase 2a IPF study; IDMC recommends continuation","bullets":["6-week interim data from Phase 2a study of GRI-0621 in IPF show reduced fibrogenesis and increased fibrolysis in treated patients.","IDMC recommended study continue as planned; no safety concerns seen to date.","Phase 2a study fully enrolled; topline data expected Q3 2025.","GRI-0621 patients demonstrated increased basement membrane remodeling and potential repair mechanism vs control.","Additional pulmonary function test results expected in coming weeks; flow cytometry and gene expression data later."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-25-000094","json":"https://secwatch.observer/filing/0001824293-25-000094.json","markdown":"https://secwatch.observer/filing/0001824293-25-000094.md","text":"https://secwatch.observer/filing/0001824293-25-000094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000094/0001824293-25-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000094/val-20250731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:26:51.103331+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}